ADVERTISEMENT



Google       

Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs

OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense

Find a Local Lawyer

Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402

Bookmark

Patent Law

: Patent Docs

Pfizer and Biocon Sign Global Commercialization Agreement on Biosimilars

By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry

ADVERTISEMENTS
By Donald Zuhn -- Since President Obama signed the Patient Protection and Affordable Care Act into law in March, thereby establishing an approval pathway for biosimilar biological products, the biotech industry has waited to see which company might be the first to take advantage of the new approval pathway. Last week, Pfizer Inc. joined a growing list of candidates when it announced that it had entered into a strategic global agreement with India's largest biotech company, Biocon Ltd., for the worldwide commercialization of Biocon's biosimilar versions of Insulin and Insulin analog products: Recombinant Human Insulin, Glargine, Aspart, and Lispro. Under...

Full post as published by Patent Docs on October 28, 2010 (boomark / email).

Bloggers, promote your law blog by nominating your blog for inclusion in USLaw.com's Law Blog Directory and RSS Reader. Benefits described.
Related Law Articles

Prenuptial Agreements
Make an Airtight Prenuptial Agreement

Uniform Pre-marital Agreement Act
Standard Prenuptial Law

Bextra Product Recall
Find a Bextra Lawyer

Bextra Injury Risks
Bextra Increases Risk of Fatal Heart Attack

Lawsuits and Settlements

Pfizer, Pharmacia
Found Guilty of Medicaid Fraud

Loan Agreement
Vernalis to pay Endo Pharmaceuticals $7 million settlement.

Pfizer
Will Pay $975,000 In Clean Air Settlement

Merger Agreement Rejected
Finish Line and Genesco reach $175 million settlement in merger dispute.

Compound License
Palatin Technologies pays Competitive Technologies $800,000 agreement dispute settlement.

Cipro
The FDA is seeking to add black box warnings of the risk of tendon rupture associated with Cipro and Levaquin. The ruptures can involve Achilles tendon, shoulder, hand, bicep or thumb tendons, and is especially increased in patients older than 60, or people who have received kidney, heart or lung transplants, as well as people on steroid therapy...

Related Searches

























































































































US Law
#1 Online Legal Resource













Your Blog Subscriptions
Subscribe to blogs

10,000+ Law Job Listings
Lawyer . Police . Paralegal . Etc
Earn a law-related degree
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.


Practice Area
Zip Code:

Contact a Lawyer Now!






0.0126 secs (new cache)